The Ivory Embassy in 2019 and 2020 – how we deliver scientific thinking
Reading Time: 4 minutes We know it’s too late to say it, but what the heck! Happy new year, fam! Lovers, haters, and in between, all of you. “Why the sudden good mood?” you ask. Because 2019 treated us well, 2020 looks promising already, and we’re now psyched to share our accomplishments of the past year and our plans…
1 year after birth: are CRISPR-designed babies the future?
Reading Time: 6 minutes The German news site n-tv.de interviewed me about a week ago about the possibilities and risks of the CRISPR gene-editing technology. The reason for this piece was the first anniversary of the CRISPR manipulated twins (with the pseudonyms Lulu and Nana). In short, a Chinese researcher and former associate professor at the Southern University of…
Should we fight fake fire with fire? Creating better scientific stories and anecdotes
Reading Time: 6 minutes Using anecdotes in a scientific context may be a double-edged sword. Still, we need captivating strategies to replace pseudoscientific stories with better ones without losing accuracy and trust. The time my niece got a triple vaccine shot Let me tell you about the time my niece received a triple vaccination shot. She was about a…
Modifying multiple genes and hoping to treat diseases with CRISPR-Cas12a
Reading Time: 4 minutes A Swiss team figured out how to modify multiple genes in one cell using the gene-editing CRISPR-system Cas12a. What do the findings mean for disease treatment strategies? In May, during our Amsterdam S.H.I.T. Show, we talked about the gene-editing CRISPR-Cas systems and how they enable you to cut DNA almost anywhere you want. The tools…
Blue is for Girls, Pink is for Boys
Reading Time: 6 minutes “Is it a boy or a girl?” The first question we ask about a new baby. But can we honestly answer it? Or is this distinction between male and female sex or gender trickier than we think? In our society, we accept that genitalia determines our sex and gender: if you are born with a…
S.H.I.T. Show to the people! (an update)
Reading Time: 4 minutes OK, so we arranged our first ever Science&Health Informal Talk (S.H.I.T.) Show in Amsterdam. We uploaded pictures from it on our social media, but where’s that written update we promised you?? Sorry for the delay, but it’s summer here. Plus, the preparation for the event took some time and accumulated our responsibilities outside the Ivory…
The Upcoming S.H.I.T. Show and How It All Started, Interviewing the Organizers
Reading Time: 5 minutes In case you haven’t heard, the Ivory Embassy is organizing the upcoming Science & Health Informal Talk Show (or simply the S.H.I.T. Show). The event DNA Manipulation: Treating Diseases and Designing Babies with CRISPR takes place in Amsterdam on May 23rd and will highlight the implications of CRISPR-Cas – a new biotechnological tool that can…
Epigenetics: the making of a concert
Reading Time: 4 minutes Epigenetics: the making of a concert Epigenetics is important for the development of an organism. It’s also an important process in cancer, and a potential target in the battle against it. Word has it that epigenetics is “hot” as fudge in research. It’s the present and future they say. Don’t believe me? Ask my mom;…
Genome edited CRISPR babies are born
Reading Time: 3 minutes It finally happened. The first CRISPR edited babies were recently born! Or that’s the claim at least. He Jiankui, a scientist from the Southern University of Science and Technology of China in Shenzhen claims to have disabled a gene important for HIV infections. He edited embryos using CRISPR, which he then used for in vitro…
The top six reasons only some diseases are treated in CRISPR clinical trials… for the moment
Reading Time: 6 minutes The top six reasons only some diseases are treated in CRISPR clinical trials… for the moment Damn, this CRISPR-thing escalated fast. In 2013, we could read the first reports of the genome editing tool CRISPR-Cas9 being used in human and mouse cells and just two years later it was suddenly possible to change genes in…